Curtis Bamber is a biopharma commercial leader and marketer with extensive experience in strategic leadership, therapeutic insights, and diverse markets. They have successfully led numerous launches in therapeutic areas such as hepatitis C and biosimilars, including the first infliximab biosimilar. From 2010 to 2023, Curtis held key positions at notable companies such as Bristol-Myers Squibb, Hospira, and Pfizer, where they excelled in market access, strategic partnerships, and commercial development. Curtis is currently pursuing a Bachelor of Commerce in Marketing and Finance at the University of Saskatchewan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices